Alani Sulaimon Akanmu (Alani S Akanmu)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

PloS one

PLoS neglected tropical diseases

Scientific reports

Andrologia

Lagos University Teaching Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lagos University Teaching Hospital

Nigeria

Consultant Haematologist :: Haematology and Blood Transfusion

University of Lagos College of Medicine

Nigeria

Lecturer in Haematology and Blood Transfusion :: Haematology and Blood Transfusion

Lagos University Teaching Hospital

Nigeria

Resident Haematologist :: Haematology

Publications

Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Opeyemi Abudiore, Ikechukwu Amamilo, Jennifer Campbell, Williams Eigege, Joseph Harwell, James Conroy, Justus Jiboye, Folu Lufadeju, Carolyn Amole, Owens Wiwa, Damien Anweh, Oche Ochai Agbaji, Alani Sulaimon Akanmu
High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria. PloS one 18 (5) (2023)
Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Opeyemi Abudiore, Ikechukwu Amamilo, Jennifer Campbell, Williams Eigege, Joseph Harwell, James Conroy, Justus Jiboye, Folu Lufadeju, Carolyn Amole, Owens Wiwa, Damien Anweh, Oche Ochai Agbaji, Alani Sulaimon Akanmu
High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria. PloS one 18 (5) (2023)
Opeyemi Abudiore, Ikechukwu Amamilo, Jennifer Campbell, Williams Eigege, Joseph Harwell, James Conroy, Justus Jiboye, Folu Lufadeju, Carolyn Amole, Owens Wiwa, Damien Anweh, Oche Ochai Agbaji, Alani Sulaimon Akanmu
High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria. PloS one 18 (5) (2023)
Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Kehinde Sharafadeen Okunade, Kabir B Badmos, Austin C Okoro, Iyabo Y Ademuyiwa, Yusuf A Oshodi, Adebola A Adejimi, Nicholas A Awolola, Oluchi Ozonu, Hameed Adelabu, Gbenga Olorunfemi, Alani Sulaimon Akanmu, Adekunbiola A Banjo, Rose I Anorlu, Jonathan S Berek
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol. PloS one 18 (1) (2023)
Edidiong Nnamso Akang, Olufunke O Dosumu, Ann A Ogbenna, Utom-Obong U Akpan, Jane C Ezeukwu, Mayowa O Odofin, Ademola A Oremosu, Alani Sulaimon Akanmu
The impact of dolutegravir-based combination antiretroviral therapy on the spermatozoa and fertility parameters of men living with human immunodeficiency virus. Andrologia 54 (11) (2022)
Omoladun O Odediran, Oluwakemi Ololade Odukoya, Mobolanle R Balogun, Jonathan A Colasanti, Alani Sulaimon Akanmu
A Qualitative Study Exploring Factors Associated with Retention in HIV Care among Women with HIV in a Large HIV Clinic in Lagos, Nigeria, after Implementing the Test and Treat Policy. AIDS research and treatment 2022 (2022)
Bobby Brooke Herrera, Donald J Hamel, Philip Oshun, Rolake Akinsola, Alani Sulaimon Akanmu, Charlotte A Chang, Philomena Eromon, Onikepe Folarin, Tolulope A Kayode, Christian T Happi, Yichen Lu, Folasade Ogunsola, Phyllis J Kanki
A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals. PLoS neglected tropical diseases 12 (5) (2018)
Seth C Inzaule, Cissy M Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, Tamara Sonia Boender, Pascale Ondoa, Kim C E Sigaloff, Denise Naniche, Tobias F Rinke de Wit, Raph L Hamers
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance. Scientific reports 8 (1) (2018)
Titilope A Adeyemo, Oyesola O Ojewunmi, Idat A Oyetunji, Helen Rooks, David C Rees, Adebola O Akinsulie, Alani Sulaimon Akanmu, Swee Lay Thein, Stephan Menzel
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia. PloS one 13 (6) (2018)

Alani Sulaimon Akanmu.css-eqlu8i{font-size:small;padding-left:4px;} (Alani S Akanmu)

Publication Activity (10 Years)

Top Topics

Top Venues

Alani Sulaimon Akanmu (Alani S Akanmu)